Drugs / BOS-356
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04163263 | Nov 2019 → Nov 2020 | adult acne | Boston Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BOS-356 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04163263 ↗ |
| Route | Topical | “twice daily (BID) topical applications of BOS-356 gel” NCT04163263 ↗ |